General MedicationsSUBCUTANEOUSStandard
OVIDREL
CHORIOGONADOTROPIN ALFA
Standard Dose
EQ 0.25MG /0.5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview OVIDREL is listed in Drugs@FDA under application 021149 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CHORIOGONADOTROPIN ALFA Form and strength INJECTABLE;SUBCUTANEOUS - EQ 0.25MG /0.5ML Sponsor EMD SERONO Submission history Latest submission status date: 2015-09-30 00:00:00.
Structured Monograph
Clinical summary
Approval overview OVIDREL is listed in Drugs@FDA under application 021149 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient CHORIOGONADOTROPIN ALFA Form and strength INJECTABLE;SUBCUTANEOUS - EQ 0.25MG /0.5ML Sponsor EMD SERONO Submission history Latest submission status date: 2015-09-30 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.